Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
about
Carnitine for fatigue in multiple sclerosisCarnitine for fatigue in multiple sclerosisRole of carnitine in cancer chemotherapy-induced multiple organ toxicity.Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy.FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction.Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine.Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats.Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.Modulatory effects of L-carnitine on tamoxifen toxicity and oncolytic activity: in vivo study.Carnitine partially protects the rat testis against the late damage produced by doxorubicin administered during pre-puberty.
P2860
Q24197748-7F60F38D-7D25-4BF0-BF03-54CDADDF887DQ24240036-2E1C7112-B931-4673-BF18-0FB15A7A96E7Q38130229-909D3D8A-3C41-4475-8045-76AF0EC8120AQ39094453-4F78FD91-31DE-48B3-A720-FAA939CDDEEBQ41809461-35ECDD4F-A9E1-4051-93A7-6103B2FD03EEQ43707999-9948AE59-9CF2-40B4-AE7A-D62574CC6719Q43865650-27E4DF04-48C2-4026-A89D-5B6753CA3DA3Q44350861-D236E03B-FE92-4A66-860D-97FB22CD0D7EQ45455657-95F388BC-7439-4194-B001-C86FD9DCFEC0Q46898961-0B882649-BF3A-48B0-9EC6-A021D618D794Q50631420-98A14B44-4158-49B2-BCAC-6BED06787210
P2860
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@ast
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@en
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@nl
type
label
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@ast
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@en
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@nl
prefLabel
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@ast
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@en
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@nl
P2093
P356
P1476
Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine
@en
P2093
M M Sayed-Ahmed
S A Shouman
S Shaarawy
P304
P356
10.1006/PHRS.1998.0438
P407
P577
1999-04-01T00:00:00Z